一个可扩展的,交互式工具的随机试验的协议,以支持重症患者的代理决策者
Aleksandra E Olszewski1, Rachel A Butler1, Deepshikha C Ashana2
1Department of Critical Care Medicine, University of Pittsburgh, 3550 Terrace St, Pittsburgh, PA 15213, USA.
Contemporary clinical trials
|February 23, 2026
概括
这项研究测试了一种数字工具,并准备了会议,以改善危急病患者的终身护理. 该干预旨在加强以患者为中心,并减少在重症监护室 (ICU) 住院期间代孕母亲的痛苦.
科学领域:
- 医学伦理 医学伦理
- 临界护理医学 临界护理医学
- 卫生沟通健康沟通
背景情况:
- 危急病患者,尤其是临终期患者,往往会得到与他们的目标不一致的护理.
- 代理决策者由于沟通失败和高风险决策而经历了严重的心理痛苦.
- 这些因素包括临床医生与代孕妇的沟通不佳,缺乏预后和价值观讨论,以及未准备好的代孕妇.
研究的目的:
- 评估一项旨在改善对失能,重症成人护理的多元干预措施.
- 评估干预对以患者为中心和代理决策者的结果的影响.
- 提供证据,以加强在重症监护机构的沟通和决策.
主要方法:
- 一个多中心,随机的疗效试验,涉及370名重症患者及其代孕.
- 干预小组获得了一个数字家庭支持工具 (FST),并准备了家庭会议.
- 对照组接受了通常的重症监护室 (ICU) 护理.
主要成果:
- 测量的主要结局是使用修改的患者感知患者中心护理 (PPPC) 尺度来测量护理的患者中心性.
- 其次结果包括代孕的心理负担,沟通质量和医疗保健资源利用.
- 分析的重点是将干预组与常规护理控制组进行比较.
结论:
- 该试验将提供关于FST和增强通信的联合效应的强有力的证据.
- 研究结果将为ICU患者的患者,家庭和卫生系统的结果提供信息.
- 该研究解决了临终关怀沟通和决策支持方面的关键差距.
相关概念视频
Ethical Dilemmas II
2.5K
Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:
2.5K
Randomized Experiments
9.1K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
9.1K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
334
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
334
Blinding
4.0K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.0K
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
305
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
305


